Last reviewed · How we verify

Insulin infusion with basal insulin and bolus

Tanta University · Phase 1 active Small molecule Quality 5/100

Insulin infusion with basal insulin and bolus is a Small molecule drug developed by Tanta University. It is currently in Phase 1 development.

At a glance

Generic nameInsulin infusion with basal insulin and bolus
SponsorTanta University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Insulin infusion with basal insulin and bolus

What is Insulin infusion with basal insulin and bolus?

Insulin infusion with basal insulin and bolus is a Small molecule drug developed by Tanta University.

Who makes Insulin infusion with basal insulin and bolus?

Insulin infusion with basal insulin and bolus is developed by Tanta University (see full Tanta University pipeline at /company/tanta-university).

What development phase is Insulin infusion with basal insulin and bolus in?

Insulin infusion with basal insulin and bolus is in Phase 1.

What are the side effects of Insulin infusion with basal insulin and bolus?

Common side effects of Insulin infusion with basal insulin and bolus include Infusion site reaction.

Related